US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
US5824307A
(en)
*
|
1991-12-23 |
1998-10-20 |
Medimmune, Inc. |
Human-murine chimeric antibodies against respiratory syncytial virus
|
US20020102257A1
(en)
*
|
1998-09-21 |
2002-08-01 |
Leslie Sid Johnson |
Human-murine chimeric antibodies against respiratory syncytial virus
|
US6685942B1
(en)
*
|
1993-12-10 |
2004-02-03 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to respiratory syncytial virus
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
DE69738333T2
(de)
*
|
1997-10-01 |
2008-11-27 |
Novadel Pharma Inc. |
Nichtpolares Spray zur bukkalen Verabreichung
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
US20040136914A1
(en)
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
EP1071458A4
(en)
|
1998-03-13 |
2005-02-16 |
Dana Farber Cancer Inst Inc |
HUMANIZED ANTIBODIES AND ITS USES
|
AR030019A1
(es)
*
|
1999-05-18 |
2003-08-13 |
Smithkline Beecham Corp |
Anticuerpos monoclonales humanos y fragmentos funcionales del mismo, un procedimiento para su produccion, composiciones farmaceuticas que los comprenden, una molecula aislada de acido nucleico, un plasmido recombinante, una celula hospedante y el uso de dichos anticuerpos para la manufactura de un m
|
US7229619B1
(en)
*
|
2000-11-28 |
2007-06-12 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
ATE474854T1
(de)
|
2000-01-27 |
2010-08-15 |
Medimmune Llc |
Rsv neutralisierende antikörper mit sehr hohen affinität
|
US20010034062A1
(en)
*
|
2000-02-09 |
2001-10-25 |
Scott Koenig |
Antibody gene therapy with adeno-associated viral vectors
|
US7700735B2
(en)
|
2000-03-01 |
2010-04-20 |
Medimmune, Llc |
High potency recombinant antibodies and method for producing them
|
WO2001064248A1
(en)
*
|
2000-03-02 |
2001-09-07 |
Medimmune, Inc. |
Methods of enhancing activity of vaccines and vaccine compositions
|
AU6113701A
(en)
*
|
2000-05-03 |
2001-11-12 |
Virion Systems Inc |
Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents
|
JP2003531866A
(ja)
*
|
2000-05-03 |
2003-10-28 |
メディミューン,インコーポレイテッド |
抗体を用いた呼吸器疾患の組合せ治療法
|
US7179900B2
(en)
*
|
2000-11-28 |
2007-02-20 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6855493B2
(en)
|
2000-11-28 |
2005-02-15 |
Medimmune, Inc. |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
US6818216B2
(en)
*
|
2000-11-28 |
2004-11-16 |
Medimmune, Inc. |
Anti-RSV antibodies
|
AU2008202076B2
(en)
*
|
2000-11-28 |
2011-09-08 |
Medimmune, Llc |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
|
CA2430039C
(en)
|
2000-11-28 |
2014-01-28 |
Medimmune, Inc. |
Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment
|
EP2357187A1
(en)
|
2000-12-12 |
2011-08-17 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
US7658921B2
(en)
*
|
2000-12-12 |
2010-02-09 |
Medimmune, Llc |
Molecules with extended half-lives, compositions and uses thereof
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
KR20040002853A
(ko)
|
2001-01-19 |
2004-01-07 |
비로노바티브 비.브이. |
감응성 포유류에서 호흡계 질환을 유발하는 바이러스
|
US8715922B2
(en)
*
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
GB2378949B
(en)
*
|
2001-08-16 |
2005-09-07 |
Morten Steen Hanefeld Dziegiel |
Recombinant anti-plasmodium falciparum antibodies
|
WO2003072719A2
(en)
*
|
2002-02-21 |
2003-09-04 |
Medimmune Vaccines, Inc. |
Metapneumovirus strains and their use in vaccine formulations and as vector for expression of antigenic sequences
|
US20040063912A1
(en)
*
|
2002-03-15 |
2004-04-01 |
The Brigham And Women's Hospital, Inc. |
Central airway administration for systemic delivery of therapeutics
|
AU2002316574B2
(en)
*
|
2002-03-15 |
2008-05-01 |
Brandeis University |
Central airway administration for systemic delivery of therapeutics
|
AU2003226065B2
(en)
*
|
2002-04-12 |
2009-02-26 |
Ludwig Institute For Cancer Research, Ltd |
Recombinant anti-interleukin-9 antibodies
|
WO2004014292A2
(en)
*
|
2002-05-10 |
2004-02-19 |
Purdue Research Foundation |
EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
|
WO2003094859A2
(en)
*
|
2002-05-10 |
2003-11-20 |
Medimmune, Inc. |
Epha2 monoclonal antibodies and methods of use thereof
|
US20050152899A1
(en)
*
|
2002-05-10 |
2005-07-14 |
Kinch Michael S. |
EphA2 agonistic monoclonal antibodies and methods of use thereof
|
US7132100B2
(en)
|
2002-06-14 |
2006-11-07 |
Medimmune, Inc. |
Stabilized liquid anti-RSV antibody formulations
|
US7425618B2
(en)
*
|
2002-06-14 |
2008-09-16 |
Medimmune, Inc. |
Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
|
AU2013201261B2
(en)
*
|
2002-06-14 |
2016-06-23 |
Medimmune, Llc |
Stabilized liquid anti-RSV antibody formulations
|
JP2005533861A
(ja)
*
|
2002-07-25 |
2005-11-10 |
メデュームン,インコーポレーテッド |
抗RSV、抗hMPV、および抗PIV抗体を使用するRSV、hMPV、およびPIVの治療法と予防法
|
US7261893B2
(en)
*
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
EP1608683B1
(en)
|
2003-04-01 |
2011-11-23 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions
|
EP1617864A4
(en)
*
|
2003-04-11 |
2006-06-21 |
Medimmune Inc |
EPHA2 AND NON-NEOPLASTIC HYPERPROLIFERATIVE CELL TROUBLESHOOTING
|
EP1618184A4
(en)
*
|
2003-04-11 |
2006-06-21 |
Medimmune Inc |
EPHA2, HYPOPROLIFERATIVE CELL DISORDERS, AND EPITHELIAL AND ENDOTHELIAL RECONSTITUTION
|
ES2391087T3
(es)
|
2003-04-11 |
2012-11-21 |
Medimmune, Llc |
Anticuerpos de IL-9 recombinantes y usos de los mismos
|
CN101410519B
(zh)
|
2003-04-25 |
2013-04-24 |
免疫医疗有限责任公司 |
间质肺病毒株及其在疫苗制剂中以及用作抗原性序列表达载体的用途和繁殖病毒的方法
|
KR101187955B1
(ko)
*
|
2003-04-25 |
2012-10-08 |
비로노바티브 비브이 |
메타뉴모바이러스 유래 이종 항원을 포함하는 재조합파라인플루엔자 바이러스 발현 시스템 및 백신
|
CN1914226B
(zh)
*
|
2003-11-25 |
2012-02-01 |
达纳-法伯癌症研究院有限公司 |
SARS-CoV抗体及其使用方法
|
AU2005214988A1
(en)
*
|
2004-02-17 |
2005-09-01 |
Absalus, Inc. |
Super-humanized antibodies against respiratory syncytial virus
|
AU2005214382B2
(en)
*
|
2004-02-19 |
2011-08-04 |
Genentech, Inc. |
CDR-repaired antibodies
|
EP1755673B1
(en)
|
2004-04-12 |
2014-07-23 |
MedImmune, LLC |
Anti-il-9 antibody formulations and uses thereof
|
EP3073267A1
(en)
|
2004-09-21 |
2016-09-28 |
Medimmune, Inc. |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
US7910101B2
(en)
|
2004-10-25 |
2011-03-22 |
Centocor, Inc. |
Melanocortin receptor binding mimetibodies, compositions, methods and uses
|
TW200636064A
(en)
*
|
2004-10-28 |
2006-10-16 |
Centocor Inc |
Anti-respiratory syncytial virus antibodies, antigens and uses thereof
|
EP1812068A4
(en)
*
|
2004-10-29 |
2010-06-09 |
Medimmune Inc |
METHODS FOR PREVENTING AND TREATING RSV INFECTIONS AND ASSOCIATED DISEASES
|
AU2006223138B2
(en)
*
|
2005-03-10 |
2012-04-05 |
Medimmune, Llc |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
EP1885402A4
(en)
*
|
2005-04-08 |
2010-11-10 |
Medimmune Inc |
ANTIBODIES AGAINST METAPNEUMOVIRUS FROM MAMMALS
|
JP2008546805A
(ja)
|
2005-06-23 |
2008-12-25 |
メディミューン,エルエルシー |
最適な凝集および断片化プロフィールを有する抗体製剤
|
EP1968998A4
(en)
*
|
2005-12-21 |
2010-01-27 |
Medimmune Llc |
AFFINITY-OPTIMIZED EPHA2-AGONISTIC ANTIBODIES AND METHODS FOR THEIR USE
|
MX2008011280A
(es)
*
|
2006-03-06 |
2008-09-12 |
Symphogen As |
Anticuerpor policlonal recombinante para el tratamiento de infecciones por el virus sincitial respiratorio.
|
JP2009534387A
(ja)
*
|
2006-04-19 |
2009-09-24 |
ノヴァデル ファーマ インコーポレイテッド |
安定な含水アルコール性経口噴霧調剤物および方法
|
WO2007147090A2
(en)
|
2006-06-14 |
2007-12-21 |
Macrogenics, Inc. |
Methods for the treatment of autoimmune disorders using monoclonal antibodies with reduced toxicity
|
TW201343676A
(zh)
|
2006-08-28 |
2013-11-01 |
Kyowa Hakko Kirin Co Ltd |
具拮抗性之人類light專一性人類單株抗體
|
EP2124897A4
(en)
*
|
2006-12-22 |
2012-05-09 |
Novadel Pharma Inc |
SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS
|
CN101679513A
(zh)
*
|
2007-03-06 |
2010-03-24 |
西福根有限公司 |
用于治疗呼吸道合胞病毒感染的重组抗体
|
CN101668771B
(zh)
|
2007-03-12 |
2013-08-21 |
艾斯巴技术,爱尔康生物医药研究装置有限责任公司 |
单链抗体的基于序列的工程改造和最优化
|
US8747872B2
(en)
|
2007-05-02 |
2014-06-10 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
KR20100022974A
(ko)
*
|
2007-05-10 |
2010-03-03 |
노바델 파마 인코포레이티드 |
항불면증 조성물 및 제조 방법
|
EP1997830A1
(en)
|
2007-06-01 |
2008-12-03 |
AIMM Therapeutics B.V. |
RSV specific binding molecules and means for producing them
|
EP2158315B1
(en)
|
2007-06-25 |
2016-03-23 |
ESBATech, an Alcon Biomedical Research Unit LLC |
Methods of modifying antibodies, and modified antibodies with improved functional properties
|
KR101530723B1
(ko)
*
|
2007-06-25 |
2015-06-22 |
에스바테크 - 어 노바티스 컴파니 엘엘씨 |
단일 쇄 항체의 서열에 기초한 공학처리 및 최적화
|
US7867497B2
(en)
*
|
2007-09-24 |
2011-01-11 |
Vanderbilt University |
Monoclonal antibodies to respiratory syncytial virus and uses therefor
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
DK2285408T3
(en)
*
|
2008-06-05 |
2019-02-04 |
Ablynx Nv |
AMINO ACID SEQUENCES AGAINST COATING PROTEINS IN A VIRUS AND POLYPEPTIDES INCLUDING THESE FOR TREATMENT OF VIRUSAL DISEASES
|
SI3241843T1
(sl)
|
2008-06-25 |
2021-11-30 |
Novartis Ag |
Optimizacija topnosti imunoveziv
|
TWI445716B
(zh)
|
2008-09-12 |
2014-07-21 |
Rinat Neuroscience Corp |
Pcsk9拮抗劑類
|
EP2373689A1
(en)
|
2008-12-12 |
2011-10-12 |
MedImmune, LLC |
Crystals and structure of a human igg fc variant with enhanced fcrn binding
|
WO2010087927A2
(en)
|
2009-02-02 |
2010-08-05 |
Medimmune, Llc |
Antibodies against and methods for producing vaccines for respiratory syncytial virus
|
KR101778317B1
(ko)
|
2009-08-13 |
2017-09-13 |
얀센 백신스 앤드 프리벤션 비.브이. |
사람 호흡기 세포융합 바이러스(rsv)에 대한 항체 및 이용 방법
|
AU2010282340B2
(en)
|
2009-08-13 |
2016-12-22 |
The Johns Hopkins University |
Methods of modulating immune function
|
US8568726B2
(en)
|
2009-10-06 |
2013-10-29 |
Medimmune Limited |
RSV specific binding molecule
|
BR112012031638B1
(pt)
*
|
2010-07-09 |
2021-01-12 |
Janssen Vaccines & Prevention B.V. |
anticorpo anti-rsv ou fragmento de ligação de antígeno do mesmo, anticorpo multivalente, composição farmacêutica, uso de anticorpo ou fragmento de ligação de antígeno, método de detectar infecção por rsv, e, ácido nucleico isolado
|
US9320793B2
(en)
*
|
2010-07-14 |
2016-04-26 |
Acumen Pharmaceuticals, Inc. |
Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP2625189B1
(en)
|
2010-10-01 |
2018-06-27 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
HUE057725T2
(hu)
|
2011-10-03 |
2022-06-28 |
Modernatx Inc |
Módosított nukleozidok, nukleotidok és nukleinsavak és ezek felhasználása
|
WO2013059885A2
(en)
|
2011-10-28 |
2013-05-02 |
Cephalon Australia Pty Ltd |
Polypeptide constructs and uses thereof
|
HRP20220717T1
(hr)
|
2011-12-16 |
2022-07-22 |
Modernatx, Inc. |
Modificirani pripravci mrna
|
AU2013243947A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
TWI659968B
(zh)
*
|
2013-03-14 |
2019-05-21 |
再生元醫藥公司 |
針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
|
US9649375B2
(en)
|
2013-03-14 |
2017-05-16 |
The Administrators Of The Tulane Educational Fund |
Immunogenic peptide conjugate and method for inducing an anti-influenza therapeutic antibody response therewith
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
SG11201509982UA
(ja)
|
2013-06-06 |
2016-04-28 |
Igenica Biotherapeutics Inc |
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
WO2015120474A1
(en)
|
2014-02-10 |
2015-08-13 |
Igm Biosciences, Inc. |
Iga multi-specific binding molecules
|
BE1022441B1
(fr)
*
|
2014-02-10 |
2016-03-30 |
Univercells Sa |
Systeme, appareil et procede pour production de biomolecules
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
US9340604B1
(en)
*
|
2014-10-29 |
2016-05-17 |
Aridis Pharmaceuticals, Inc. |
Human monoclonal antibody specific for the F protein of respiratory syncytial virus (RSV)
|
US10625180B2
(en)
|
2014-10-31 |
2020-04-21 |
Arexis Ab |
Manufacturing method
|
DK3229838T3
(da)
|
2014-12-11 |
2020-10-19 |
Pf Medicament |
Anti-C10orf54-antistoffer og anvendelser deraf
|
HUE061070T2
(hu)
|
2015-03-03 |
2023-05-28 |
Kymab Ltd |
Ellenanyagok, alkalmazások és eljárások
|
CL2015002152A1
(es)
|
2015-07-31 |
2016-06-03 |
Pontificia Universidad Católica De Chile |
Anticuerpos monoclonales específicos para el antígeno p del virus respiratorio sincicial humano (vrsh), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnostico de la infección causada por vrsh
|
JO3555B1
(ar)
|
2015-10-29 |
2020-07-05 |
Merck Sharp & Dohme |
جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
|
AU2017345759A1
(en)
|
2016-10-21 |
2019-05-23 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
AU2017345786A1
(en)
|
2016-10-21 |
2019-05-23 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
WO2018075954A2
(en)
|
2016-10-21 |
2018-04-26 |
Adimab, Llc |
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
CN112740043A
(zh)
|
2018-07-20 |
2021-04-30 |
皮埃尔法布雷医药公司 |
Vista受体
|
WO2021005232A1
(en)
|
2019-07-11 |
2021-01-14 |
Umc Utrecht Holding B.V. |
Intranasal administration of neutralising antiviral antibodies
|
WO2021202463A1
(en)
|
2020-03-30 |
2021-10-07 |
Danisco Us Inc |
Anti-rsv antibodies
|